Audhya Paul K. (CIK 1860131) reported 31 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-11). Recent activity: Sell KALV (150,260 shares), Buy KALV (2,419 shares), Sell KALV (1,032 shares), Buy KALV (6,250 shares), Sell KALV (2,686 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-11 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | Sell | 150,260 | $0 |
| 2026-05-19 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | Buy | 2,419 | $0 |
| 2026-05-19 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | Sell | 1,032 | $27,616 |
| 2026-04-20 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | Buy | 6,250 | $0 |
| 2026-04-20 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | Sell | 2,686 | $54,301 |
| 2026-02-24 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | Buy | 6,250 | $0 |
| 2026-02-24 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | Buy | 5,000 | $0 |
| 2026-02-24 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | Sell | 5,354 | $83,362 |
| 2026-02-19 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | Buy | 2,419 | $0 |
| 2026-02-19 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | Sell | 1,163 | $17,445 |
| 2025-11-26 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | Sell | 5,296 | $71,231 |
| 2025-11-26 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | Buy | 5,000 | $0 |
| 2025-11-26 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | Buy | 6,250 | $0 |
| 2025-11-19 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | Buy | 6,447 | $0 |
| 2025-11-19 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | Sell | 3,075 | $44,526 |
| 2025-08-26 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | Buy | 5,000 | $0 |
| 2025-08-26 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | Sell | 2,336 | $31,349 |
| 2025-08-25 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | Buy | 6,250 | $0 |
| 2025-08-25 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | Sell | 2,942 | $38,893 |
| 2025-08-19 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | Buy | 6,446 | $0 |
| 2025-08-19 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | Sell | 2,939 | $38,765 |
| 2025-05-27 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | Buy | 5,000 | $0 |
| 2025-05-27 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | Sell | 2,146 | $24,271 |
| 2025-05-23 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | Buy | 6,250 | $0 |
| 2025-05-23 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | Sell | 2,689 | $31,945 |
Source: SEC Form 4 filings · as of 2026-06-11